本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Virax Biolabs Group Limited

0.9850
-0.0550-5.29%
成交量:6.15萬
成交額:6.13萬
市值:427.68萬
市盈率:-0.40
高:1.03
開:1.01
低:0.9848
收:1.04
資料載入中...
2025/01/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/21

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/13

SEC問詢函

Form CORRESP - Correspondence
2023/06/14

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/28

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/22

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/11/29

SEC問詢函

CORRESP [Cover] - Correspondence
2022/11/21

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/08/12

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/07/01

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/06/30

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/06/28

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/28

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/27

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/06/24

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/24

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/24

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/06/21

SEC問詢函

CORRESP [Cover] - Correspondence